Italia markets open in 2 hours 30 minutes

TEVA Jul 2024 21.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,06000,0000 (0,00%)
In data: 03:58PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0600
Aperto0,0500
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio21,00
Scadenza2024-07-19
Min-Max giorno0,0500 - 0,0600
Contratto - Min-MaxN/D
Volume16
Open InterestN/D
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.